EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Understanding the Immune Response Changes to Clinical Interventions for Epstein–Barr Virus Infection Prior to Lymphoma Development in Children After Organ Transplants ( UNEARTH )

Vikas R Dharnidharka iD, Claire Bocchini iD, Swati Choudhry, Elizabeth Moulton iD, Lujain Jaza, Joseph Dumayas, Camila Macedo iD, Elizabeth Zaragoza, Maryam Mysorewala iD, Michelle Becker-Hapak, Mark Foster, Mansi Agarwal und 11 weitere

Pediatric Transplantation · 2026-10 · 30 (10)

DOI: 10.1111/petr.70487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, online erschienen am 09.10.2026. Verfasst von Vikas R Dharnidharka und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Rutgers Robert Wood Johnson Medical School and Bristol-Myers-Squibb Children's Hospital, New Brunswick, New Jersey, USA. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Organ Transplantation, Lymphoma, Lymphoproliferative Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post‐transplant lymphoproliferative disorders (PTLD) remain a major complication of solid organ transplants (SOT), occurring in 1%–10% of patients, but in greater proportions in children. About 50%–80% of cases are Epstein–Barr Virus (EBV) associated, through partially known and still unknown mechanisms. Even in EBV seronaive SOT recipients, transplant of an SOT from an EBV seropositive donor does not always lead to peripheral blood EBV replication. Longitudinal peripheral blood EBV DNA nucleic acid testing (NAT) after SOT has not improved the individual prediction of PTLD occurrence, likely due to variable SOT recipient immune responses.

Methods

This prospective study is designed to assess longitudinal and comprehensive T and NK cell phenotyping and responses to peripheral blood EBV replication via multispectral flow cytometry and other assays. We will also compare local to central EBV NAT values and test whether torquetenovirus NAT can act as a simpler assay to predict EBV clearance. We will collect 1390 blood samples across 5 time points in the first year after 347 enrolled (278 completed) SOTs (kidney, liver, heart, lung or intestine) from three major pediatric SOT centers in the U.S.A.

Results

As of June 30, 2025, our study has enrolled 133 participants, of whom 110 have received an organ transplant (27% Hispanic ethnicity, 16% black race, median age 8 years, across all 4 major SOT types).

Conclusions

By study end, we will know the global immune responses to EBV replication across a spectrum of clinical pediatric SOT situations. We expect to find key immune mechanisms that will predict poor or delayed EBV clearance despite clinical interventions. These findings may lead to new translational immunotherapy approaches to treat EBV DNaemia or prevent PTLD. We expect that our findings will also inform EBV oncogenesis in other immunocompromised or immunocompetent populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsOrgan TransplantationLymphomaLymphoproliferative DisordersPostoperative ComplicationsHumansChildProspective StudiesHerpesvirus 4, HumanFemaleChild, PreschoolDNA, ViralAdolescentMaleKiller Cells, NaturalT-Lymphocytes

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department of Pediatrics, Rutgers Robert Wood Johnson Medical School and Bristol-Myers-Squibb Children's Hospital, New Brunswick, New Jersey, USA.
  • Texas Children's Hospital and Baylor College of Medicine, Houston, Texas, USA.
  • Cook Children's Hospital, Fort Worth, Texas, USA.
  • Washington University School of Medicine, St. Louis, USA.
  • University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Cincinnati Children's Hospital, Cincinnati, Ohio, USA.

ORCID-Profile: Vikas R Dharnidharka, Claire Bocchini, Elizabeth Moulton, Camila Macedo, Maryam Mysorewala, Kate Nolt, Raja Dandamudi, Michael Green, Todd A Fehniger, Lara Danziger-Isakov

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Dharnidharka, V. R., Bocchini, C., Choudhry, S., Moulton, E., Jaza, L., Dumayas, J., Macedo, C., Zaragoza, E., Mysorewala, M., Becker-Hapak, M., Foster, M., Agarwal, M., Goss, C. W., Schechtman, K. B., Nolt, K., Ramirez, J. D., Rios-Abdallah, E., Dandamudi, R., Green, M., …, & Danziger-Isakov, L. (2026). Understanding the Immune Response Changes to Clinical Interventions for Epstein–Barr Virus Infection Prior to Lymphoma Development in Children After Organ Transplants ( UNEARTH ). Pediatric Transplantation, 30(10). https://doi.org/10.1111/petr.70487

Vancouver

Dharnidharka VR, Bocchini C, Choudhry S, Moulton E, Jaza L, Dumayas J, et al. Understanding the Immune Response Changes to Clinical Interventions for Epstein–Barr Virus Infection Prior to Lymphoma Development in Children After Organ Transplants ( UNEARTH ). Pediatric Transplantation. 2026;30(10). doi:10.1111/petr.70487

BibTeX
@article{Dharnidharka2026,
  author = {Dharnidharka, Vikas R and Bocchini, Claire and Choudhry, Swati and Moulton, Elizabeth and Jaza, Lujain and Dumayas, Joseph and Macedo, Camila and Zaragoza, Elizabeth and Mysorewala, Maryam and Becker-Hapak, Michelle and Foster, Mark and Agarwal, Mansi and Goss, Charles W and Schechtman, Kenneth B and Nolt, Kate and Ramirez, Juan Diego and Rios-Abdallah, Eileen and Dandamudi, Raja and Green, Michael and Wylie, Kristine M and Fehniger, Todd A and Metes, Diana and Danziger-Isakov, Lara},
  title = {Understanding the Immune Response Changes to Clinical Interventions for Epstein–Barr Virus Infection Prior to Lymphoma Development in Children After Organ Transplants ( UNEARTH )},
  journal = {Pediatric Transplantation},
  year = {2026},
  volume = {30},
  number = {10},
  doi = {10.1111/petr.70487}
}
Kostenlos starten →